525 studies found for:    Open Studies | "Platelet Aggregation Inhibitors"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Platelet Aggregation Inhibitors"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Study on the Registration of Coronary Heart Disease Patients Undergoing PCI
Condition: Coronary Heart Disease
Intervention: Drug: antiplatelet agents
2 Recruiting Research of Resistance to Antiplatelet Agents and Development of Tailored Treatment Model for Patients With Coronary Artery Disease
Conditions: Cardiovascular Diseases;   Coronary Artery Disease
Intervention:
3 Recruiting The Laboratory AntiPlatelet Efficacy and Clinical Outcome Registry
Condition: Platelet Aggregation Onhibitors
Intervention: Drug: antiplatelet drugs - P2Y12 antagonists
4 Not yet recruiting REstart or STop Antithrombotic Randomised Trial in France
Condition: Cerebral Hemorrhage
Intervention: Drug: Clopidogrel or Aspirin and/or Dypyridamole
5 Recruiting Effect of Second-look Endoscopy on Peptic Ulcer Rebleeding in Patients With Early Resumption of Antiplatelet Agents
Conditions: OGD;   Gastric Ulcer Induced by Anti-platelet Agent;   Duodenal Ulcer Induced by Anti-platelet Agent
Interventions: Procedure: Second-look OGD;   Drug: Esomeprazole
6 Recruiting Registry of the Combination of Antiplatelet Agents and Anticoagulant in Atrial Fibrillation Patients With a CHA2DS2VASc Score >1 Undergoing Percutaneous Coronary Interventions
Condition: Percutaneous Coronary Intervention
Intervention: Other: the prevalence of ischemic events
7 Not yet recruiting Pharmacokinetics of Antiplatelet Drugs in Diabetic pAtients
Condition: Diabetes
Intervention: Drug: Clopidogrel, Prasugrel, Ticagrelor
8 Not yet recruiting Management of High Bleeding Risk Patients Post Bioresorbable Polymer Coated Stent Implantation With an Abbreviated Versus Prolonged DAPT Regimen
Conditions: High Bleeding Risk;   Coronary Artery Disease;   PCI
Interventions: Drug: Aspirin;   Drug: P2Y12 inhibitor;   Drug: Clopidogrel
9 Recruiting Atrial Fibrillation and Ischemic Events With Rivaroxaban in Patients With Stable Coronary Artery Disease Study
Condition: Atrial Fibrillation
Interventions: Drug: Rivaroxaban and single antiplatelet drug (aspirin, clopidogrel or prasugrel);   Drug: Rivaroxaban
10 Recruiting Apixaban Versus Antiplatelet Drugs or no Antithrombotic Drugs After Anticoagulation-associated Intracerebral Haemorrhage in Patients With Atrial Fibrillation
Conditions: Cerebral Hemorrhage;   Atrial Fibrillation
Interventions: Drug: Apixaban;   Drug: Aspirin;   Drug: Carbasalate calcium;   Drug: Clopidogrel;   Drug: Dipyridamole;   Other: No antithrombotic treatment
11 Recruiting Antithrombotic Strategy Variability In ATrial Fibrillation and Obstructive Coronary Disease Revascularized With PCI - The AVIATOR 2 Registry
Condition: Non-valvular Atrial Fibrillation
Intervention:
12 Recruiting Safety of PZ-128 in Subjects Undergoing Non-Emergent Percutaneous Coronary Intervention
Conditions: Arterial Occlusive Diseases;   Coronary Artery Disease;   Coronary Disease;   Arteriosclerosis;   Heart Diseases;   Myocardial Ischemia;   Vascular Diseases;   Acute Coronary Syndrome
Interventions: Drug: PZ-128;   Drug: Placebo
13 Recruiting IU Health Krannert Personalized Medicine Study
Condition: Coronary Artery Disease
Intervention: Genetic: CYP2C19 genotyping
14 Recruiting The Inhibition of Platelet Antiaggregating Activity of Clopidogrel by Atorvastatin Detected by Erythromycin Breath Test: a Metabolic Inhibition of Hepatic Cytochrome P450-3A
Conditions: Hypercholesterolemia;   Thrombosis
Interventions: Drug: Clopidogrel;   Drug: Atorvastatin
15 Recruiting Impact of Anticoagulants and Antiplatelets in Patients on Transurethral Resection of the Prostate
Conditions: Benign Prostatic Hyperplasia;   Prostate Cancer
Intervention:
16 Recruiting ShorT and OPtimal Duration of Dual AntiPlatelet Therapy-2 Study
Condition: Coronary Artery Disease
Interventions: Drug: 1-month DAPT;   Drug: 12-month DAPT
17 Not yet recruiting Secondary Prevention of Cardiovascular Disease in the Elderly Trial
Conditions: Myocardial Infarction;   Cardiovascular Disease
Interventions: Drug: Cardiovascular Polypill;   Drug: Treatment Prevention for Secondary CV
18 Recruiting A Randomized Controlled Trial of TNK-tPA Versus Standard of Care for Minor Ischemic Stroke With Proven Occlusion
Condition: Stroke, Acute
Interventions: Drug: Tenecteplase;   Drug: Antiplatelet treatment
19 Recruiting Antiplatelet Therapy Effect on Platelet Extracellular Vesicles in Acute Myocardial Infarction
Condition: Myocardial Infarction
Interventions: Drug: Ticagrelor;   Drug: Clopidogrel
20 Recruiting Bedside Testing of CYP2C19 Gene for Treatment of Patients With PCI With Antiplatelet Therapy
Conditions: Coronary Artery Disease;   Myocardial Infarction;   Heart Disease;   Vascular Disease;   Angina Pectoris;   Cardiovascular Disease;   Ischemia;   Infarction;   Embolism;   Thrombosis;   Chest Pain
Interventions: Drug: clopidogrel;   Drug: Ticagrelor or prasugrel

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.